Company · founded 2002
Cellectar Biosciences (United States)
Madison, United States · cellectarbiosciences.com
- Citations, last 5 years
- 34
- Works, last 5 years
- 14
- h-index
- 24
- Scientists listed
- 2
- Grants since 2016
- 11
Grants received
2023–2025 · research · R44
Quantitative Analysis of Cancer-associated EVs
John P Nolan · Cellectar Biosciences (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Quantitative Analysis of Cancer-associated EVs
John P Nolan · Cellectar Biosciences (United States) · funded by National Institutes of Health
2022–2024 · research · R44
A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults with Inoperable Relapsed or Refractory High Grade Glioma
Jarrod Longcor · Cellectar Biosciences (United States) · funded by National Institutes of Health
2022–2024 · research · R44
A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults with Inoperable Relapsed or Refractory High Grade Glioma
Jarrod Longcor · Cellectar Biosciences (United States) · funded by National Institutes of Health
2021–2024 · research · R44
An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia
John Friend · Cellectar Biosciences (United States) · funded by National Institutes of Health
2021–2024 · research · R44
An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia
Jarrod Longcor · Cellectar Biosciences (United States) · funded by National Institutes of Health
2021–2024 · research · R44
An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia
Jarrod Longcor · Cellectar Biosciences (United States) · funded by National Institutes of Health
2020–2023 · research · R44
Assays and kits for MSC-derived extracellular vesicles
John P Nolan · Cellectar Biosciences (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Assays and kits for MSC-derived extracellular vesicles
John P Nolan · Cellectar Biosciences (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Identification of Cell Type-specific EVs for Neuroscience Research
John P Nolan · Cellectar Biosciences (United States) · funded by National Institutes of Health
2019–2021 · research · R44
Identification of Cell Type-specific EVs for Neuroscience Research
John P Nolan · Cellectar Biosciences (United States) · funded by National Institutes of Health